Exact Sciences Raises $27.1M in Public Offering | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Exact Sciences today said that it has raised net proceeds of $27.1 million in a public offering of common stock.

The company sold a total of 3,593,750 shares of its common stock at $8 per share. The underwriters on the offering exercised their over-allotment option in full, Exact Sciences said.

RW Baird acted as sole book-running manager in the offering. William Blair was co-manager.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.